• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • Our Services
  • Contact Us
  • Newsletter
  • Top Nav Social Icons

FindBiometrics

FindBiometrics

Global Identity Management

CLEAR
  • Biometrics
    • What are Biometrics?
    • FAQ
    • Biometric Associations
    • Companies
    • Premier Partners
  • News
    • Featured Articles
    • Interviews
    • Thought Leadership
    • Podcasts
    • Webinars
    • Year in Review
  • Applications
    • Biometric Security
    • Border Control and Airport Biometrics
    • Consumer and Residential Biometrics
    • Financial Biometrics
    • Fingerprint & Biometric Locks
    • Healthcare Biometrics
    • Justice and Law Enforcement Biometrics
    • Logical Access Control Biometrics
    • Mobile Biometrics
    • Other Biometric Applications
    • Physical Access Control Biometrics
    • Biometric Time and Attendance
  • Solutions
    • Behavioral Biometrics
    • Biometric Sensors and Detectors
    • Facial Recognition
    • Biometric Fingerprint Readers
    • Hand Readers & Finger Scanners
    • Iris Recognition
    • Biometric Middleware and Software
    • Multimodal Biometrics
    • Physiological Biometrics
    • Smart Cards
    • Vein Recognition
    • Voice and Speech Recognition
  • Stocks
  • Events
  • Directory
  • Podcasts

Cancer Researchers to Use Biometric Wearables in New Study

March 5, 2021

BioIntelliSense’s wearable BioSticker will soon be used to gather data in clinical trials with cancer patients. To that end, the company has formed a strategic partnership with The Leukemia & Lymphoma Society (LLS), which will be using the stickers to monitor the vital signs of the hematological cancer patients in the study.

Cancer Researchers to Use Biometric Wearables in New Study

The BioIntelliSense BioSticker is an FDA-approved single-use device that can be worn on the body for a period of up to 30 days. The data collected with the device can be consolidated and analyzed using the company’s Data-as-a-Service platform, which will also be provided to LLS through the new strategic partnership.

LLS will use the data generated with the BioSticker to gauge the effectiveness of different treatments, linking those treatments to a patient’s symptoms to see how well they respond. The BioSticker is able to track a number of different metrics, including body temperature, heart rate, respiration, and body position.

“Our medical grade devices and data services can have a profound impact on oncology care by unlocking unique and actionable clinical intelligence to guide treatment decisions,” said BioIntelliSense CEO James Mault. “We are extremely proud to be partnering with The Leukemia & Lymphoma Society as a global leader in blood cancer research and support services.”

The BioSticker received FDA approval and was cleared for commercial launch in January of 2020, shortly ahead of the international spread of COVID-19. The pandemic generated much more interest in remote patient monitoring solutions that can provide doctors with accurate medical data while minimizing the need for in-person contact.

BioIntelliSense has since supplemented the BioSticker with the release of a 5G BioHub that will automatically consolidate patient data and upload that data to the cloud. The company also updated its Data-as-a-Service platform to better track common symptoms like sneezing and coughing in real time.

–

(Originally posted on Mobile ID World)

Related News

  • Healthcare Biometrics Month: The Remote Care FrontierHealthcare Biometrics Month: The Remote Care Frontier
  • CrossFit Names WHOOP Biometric Band As Its Official WearableCrossFit Names WHOOP Biometric Band As Its Official Wearable
  • Canaria Provides Biometric Wearables for Workplace Safety Trial in AustraliaCanaria Provides Biometric Wearables for Workplace Safety Trial in Australia
  • BioIntelliSense Updates Patient Monitoring Platform to Track Common SymptomsBioIntelliSense Updates Patient Monitoring Platform to Track Common Symptoms
  • Chronolife Announces Funding, Launch of Biometric Smart ShirtChronolife Announces Funding, Launch of Biometric Smart Shirt
  • FDA Approves Tiger Tech’s Wearable COVID-19 Detection SystemFDA Approves Tiger Tech’s Wearable COVID-19 Detection System

Filed Under: News Tagged With: BioIntelliSense, biometric wearables, BioSticker, cancer treatment, healthcare biometrics, heart rate tracking, physiological biometrics, respiration tracking, temperature tracking, The Leukemia & Lymphoma Society, wearable devices

Primary Sidebar

Iris ID

Register For Our Upcoming Event:

NEC IDelight

Sponsored Links

AU10TIX, an identity management company headquartered in Israel, provides critical, modular solutions to link physical and digital identities so that companies and their customers can confidently connect.

CMITech is a leading provider of high performance, cost effective iris recognition systems. The company is setting the industry standard for advanced user interfaces that are fast, intuitive and effortless. Serving enrollment and authentication solutions of all sizes, CMITech systems include binoculars-type, wall mount, desktop, and kiosk-type product configurations.

Onfido is building the new identity standard for the internet.Our AI-based technology assesses whether a user’s government-issued ID is genuine or fraudulent, and then compares it against their facial biometrics. That’s how we give companies like Revolut, Zipcar and Bitstamp the assurance they need to onboard customers remotely and securely. Our mission is to create a more open world, where identity is the key to access.. For more information, please visit
www.onfido.com
TECH5 is an international technology company headquartered in Geneva, Switzerland, with branches in the US, Europe and Asia, dedicated to the design, development, and distribution of biometrics-driven Identity Management solutions. Target markets include Government and Private sectors with products powering Civil ID, Digital ID, eKYC, Digital Onboarding, Visitor Management and others. Learn more:
www.tech5.ai
ThreatMark brings trust to the digital world by providing cutting-edge fraud prevention solutions. Major banks use ThreatMark's AI-powered technology and behavioral biometrics to build secured banking experience to precisely verify their legitimate users, seamlessly across all digital channels. All while securing the users' most precious assets and keeping the fraudsters away. Learn more:
www.threatmark.com/
NEC IDelight
MobileIDWorld

Mobile ID World is here to bring you the latest in mobile authentication solutions and application providers. Our company is dedicated to providing users with the best content and cutting edge information on technology, news, and mobile solutions for your mobile identity management needs.

IDEMIA big box

Recent Posts

  • Corporate Moves and Face Biometrics: This Week’s Top Stories
  • KONA I Receives Mastercard Letter of Approval for Payment Card Featuring Precise Biometrics
  • BONAFiDEE Upgrades Identity Verification Solution With Active Liveness Detection
  • Vision-Box Extends Biometric Screening Contract With Sint Maarten Airport
  • Keyless Rides New Partnerships to Another $3 Million in Seed Funding

Biometric Associations

IBIA and fido
NEC IDelight

Tweets

Footer

  • About Us
  • Company Directory
  • Advertise With Us
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • Archives

Follow Us

Copyright © 2021 FindBiometrics